Pinnacle Associates LTD Bicycle Therapeutics PLC Transaction History
Pinnacle Associates LTD
- $6.21 Billion
- Q2 2024
A detailed history of Pinnacle Associates LTD transactions in Bicycle Therapeutics PLC stock. As of the latest transaction made, Pinnacle Associates LTD holds 242,001 shares of BCYC stock, worth $5.62 Million. This represents 0.08% of its overall portfolio holdings.
Number of Shares
242,001
Previous 80,090
202.16%
Holding current value
$5.62 Million
Previous $1.99 Million
145.64%
% of portfolio
0.08%
Previous 0.03%
Shares
2 transactions
Others Institutions Holding BCYC
# of Institutions
111Shares Held
40.7MCall Options Held
3.4KPut Options Held
12.4K-
Baker Bros. Advisors LP New York, NY9.4MShares$218 Million2.53% of portfolio
-
Deep Track Capital, LP Greenwich, CT3.49MShares$81 Million2.32% of portfolio
-
Ra Capital Management, L.P. Boston, MA2.25MShares$52.3 Million0.69% of portfolio
-
Fcpm Iii Services B.V. Naarden, P72.12MShares$49.3 Million6.34% of portfolio
-
Armistice Capital, LLC New York, NY1.97MShares$45.8 Million0.52% of portfolio
About BICYCLE THERAPEUTICS plc
- Ticker BCYC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 29,676,100
- Market Cap $689M
- Description
- Bicycle Therapeutics plc, a clinical-stage biopharmaceutical company, develops a class of medicines for diseases that are underserved by existing therapeutics. Its lead product candidate is BT1718, a bicycle toxin conjugate (BTC), which is in Phase I/IIa clinical trials targeting tumors that express Membrane Type 1 matrix metalloprotease. The co...